Saturna Capital Corp Eli Lilly & CO Transaction History

Saturna Capital Corp

$7.5 Billion
Q3 2024

A detailed history of Saturna Capital Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Saturna Capital Corp holds 649,411 shares of LLY stock, worth $499 Million. This represents 7.67% of its overall portfolio holdings.

Number of Shares

649,411

Previous 682,898 4.9%

Holding current value

$499 Million

Previous $618 Million 6.95%

% of portfolio

7.67%

Previous 8.29%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$772.14 - $960.02 $25.9 Million - $32.1 Million	-33,487 Reduced 4.9%	649,411 $575 Million
Q2 2024 Jul 31, 2024	SELL	$724.87 - $909.04 $7.04 Million - $8.83 Million	-9,711 Reduced 1.4%	682,898 $618 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $11.1 Million - $14.8 Million	-18,697 Reduced 2.63%	692,609 $539 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $25.7 Million - $30.3 Million	-48,927 Reduced 6.44%	711,306 $415 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $15.4 Million - $21.2 Million	-35,435 Reduced 4.45%	760,233 $408 Million
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $403,351 - $539,327	-1,150 Reduced 0.14%	795,668 $373 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $5.63 Million - $6.61 Million	-18,125 Reduced 2.22%	796,818 $274 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $217,689 - $253,651	-677 Reduced 0.08%	814,943 $298 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $4,447 - $5,068	-15 Reduced -0.0%	815,620 $264 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $29.2 Million - $34.3 Million	-104,750 Reduced 11.38%	815,635 $264 Million
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $11,734 - $14,583	50 Added 0.01%	920,385 $264 Million
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $7,195 - $8,929	32 Added 0.0%	920,335 $245 Million
Q3 2021 Nov 08, 2021	BUY	$221.6 - $272.71 $114,124 - $140,445	515 Added 0.06%	920,303 $215 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $223,475 - $289,299	-1,360 Reduced 0.15%	919,788 $172 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $7,175 - $9,494	55 Added 0.01%	921,148 $156 Million
Q3 2020 Feb 12, 2021	BUY	$146.22 - $169.13 $135 Million - $156 Million	921,093 New	921,093 $136 Million
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $135 Million - $156 Million	-921,108 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $7.14 Million - $8.84 Million	-60,000 Reduced 6.12%	921,108 $128 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $22,425 - $24,393	-210 Reduced 0.02%	981,108 $110 Million
Q2 2019 Jul 31, 2019	BUY	$110.79 - $129.32 $89,739 - $104,749	810 Added 0.08%	981,318 $109 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $500,004 - $588,541	-4,492 Reduced 0.46%	980,508 $127 Million
Q2 2018 Aug 02, 2018	SELL	$75.7 - $86.88 $12.1 Million - $13.9 Million	-160,000 Reduced 13.97%	985,000 $84.1 Million
Q1 2018 May 10, 2018	SELL	$74.21 - $87.6 $7.42 Million - $8.76 Million	-100,000 Reduced 8.03%	1,145,000 $88.6 Million
Q4 2017 Feb 06, 2018	BUY	$81.94 - $87.89 $26,630 - $28,564	325 Added 0.03%	1,245,000 $105 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $28,901 - $32,077	375 Added 0.03%	1,244,675 $106 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,244,300	1,244,300 $102 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.

Account

Saturna Capital Corp Eli Lilly & CO Transaction History